baber/WOPTO huggingface dataset:
Patent JP-2000503436-A (JP)
IPC: G06K19/077
Filed: 1997-01-23
Abstract: A data card includes a card body having at least one card top layer and at least one card bottom layer. The outer dimensions of the top and bottom card layers correspond to one another, and a module element is fitted in between the card top layer and card bottom layer. The module element has an integrated electronic circuit for processing and/or storing personal data. A levelling compensating layer has a levelling material and is disposed or formed between the module element and the card top layer and/or the card bottom layer for filling existing cavities in the module element or between the module element and the card top layer and/or card bottom layer. The levelling compensating layer also fills or levels existing protruding elevations on a surface of the module element.
Patent JP-H11502814-A (JP)
IPC: A61P31/12
Filed: 1996-01-26
Abstract: Benzothiophene, benzofuran and indolethiazepinones, oxazepinones, and diazepinones are effective therapeutic agents for treating viral diseases, including those caused by herpesvirus and HIV.
Patent JP-H10504675-A (JP)
Title: パルス光を有する履き物
IPC: A43B13/14
Filed: 1995-04-28
Abstract: (57)【要約】
履き物に用いられパルス光を発生する装置（３０）は靴のソール（２０）に配置され得る。この装置は、履いている人の圧力に応答し、一定期間、あるいは再び操作されるまでの間、発光回路を付勢するスイッチ（３８）を有する回路を有する。発光回路は靴のソール（２０）の外部で可視のパルス光を発生する。この回路は履いている人の足が地面に接触したり、地面から離れた時に動作するように制御される。
Patent JP-H09512910-A (JP)
IPC: G01N33/68
Filed: 1995-05-04
Abstract: The invention relates to a method for assaying for the presence of a substance that modulates a cytokine of the TGF beta  superfamily. A substance which is suspected of modulating a cytokine of the TGF beta  superfamily and a TGF beta  binding compound which is not a TGF beta  receptor and which contains a TRH1 domain, or a portion or mimetic thereof, is reacted with a cytokine of the TGF beta  superfamily under conditions where the compound, portion or mimetic thereof, and the cytokine are capable of forming a complex. Complexes, free compound and/or cytokine are assayed and compared with a control. The invention also relates to a composition comprising at least one compound which is not a TGF beta  receptor and which contains the TRH1 domain or a portion, or a mimetic thereof, and a pharmaceutically acceptable carrier, auxiliary or excipient and to methods of treatment using the composition. Further the invention relates to a method of enhancing the activity of growth factors.
Patent JP-2000505847-A (JP)
Title: 粒子状材料を含むドライレイされた構造体
IPC: A61L15/60
Filed: 1997-12-15
Abstract: (57)【要約】
本発明は、水性流体を吸収するためおよび／または悪臭抑制をもたらすためのドライレイされた繊維質構造体（４０）に関する。繊維質構造体（４０）は、ドライレイされた繊維質ウェブ（２２）と、ウェブ中に分配された粒子状材料（４２）とを含み、その中に分配された微細に分割された状態の熱可塑性ポリマー材料（４８）により結合され；繊維質構造体（４０）は、使い捨て吸収製品中での使用に特に適切である。
Patent JP-H11504458-A (JP)
Title: スーパースカラマイクロプロセッサにおける分岐予測正確度向上のための装置および方法
IPC: G06F9/38
Filed: 1997-02-10
Abstract: (57)【要約】
本方法および装置は、コンピュータの条件付き分岐命令が行使されるべきか行使されるべきでないかを予測する。履歴レジスタは命令グループの履歴の記録を維持し、各グループに対して一回更新される。この履歴レジスタと各グループの一個の命令の一個のバイトのアドレスとが、２ビット飽和カウンタのテーブルへのアドレスを形成するように添付されまたは別の方法として結合される。形成されたアドレスにおけるカウンタの一個のビットの値は、そのグループ内の各分岐のための全ての条件付き分岐命令を予測するために、用いられる。
Patent JP-2001510577-A (JP)
Title: 干渉計システムおよびそのようなシステムを含むリソグラフィー装置
IPC: G01B9/02
Filed: 1998-11-27
Abstract: (57)【要約】
物体（ＷＨ）上に配置したＸおよび／またはＹ測定ミラー（Ｒ 1 、Ｒ 2 ）と協同する複数のＸおよび／またはＹ測定軸（ＭＡＸ，１、ＭＡＸ，２、ＭＡＸ，３、ＭＡＸ，４、ＭＡＸ，５）を有する、複合干渉計システムを記載する。この干渉計システムは、部分的にＸＹ平面で伸び並びにこの物体上に配置したＺ測定ミラー（Ｒ’ 3 、Ｒ’ 4 ）、およびＺ反射器（１６４、１６８）と協同する、少なくとも一つのＺ測定軸（ＭＡＸ，７、ＭＡＸ，９）も有する。それで、簡単な手段を使って、この干渉計システムでより正確且つ確実な測定ができることを保証する。
Patent JP-2000504744-A (JP)
Title: ε―カプロラクタム、６―アミノカプロン酸および６―アミノカプロン酸アミドの混合物の製造法
IPC: C07D201/12
Filed: 1997-02-12
Abstract: (57)【要約】
アンモニアならびに６−アミノカプロン酸および／または６−アミノカプロン酸アミドのオリゴマーを含む水性混合物を加熱することによりε−カプロラクタム、６−アミノカプロン酸、６−アミノカプロン酸アミドの混合物を製造する方法において、水性混合物が０．５〜７重量％の等価アンモニア（ＮＨ 3 として計算）を含み、温度が２８０℃〜３３０℃であり、ここで、「等価アンモニア」とは、遊離アンモニアおよび水性混合物に存在する化合物の一つの末端アミド基の形で存在するアンモニアを意味することを特徴とする方法。
Patent JP-H11504135-A (JP)
Title: 音響減衰構造体、及びその製造方法
IPC: B60R13/08
Filed: 1996-04-24
Abstract: (57)【要約】
本発明は、カーステレオのラウドズピーカを含む構造における音響減衰吸収効果を達成するための構造体（１）に関する。粘着機能を有する粘弾性ポリマー（２）が、スプレー、ブラシでの塗布、ローラでの塗布、若しくはこてによる塗布によって、２つの板状の要素（３、４）の間に塗布されて、組み合わせシートが形成され、この組み合わせシートは、振動の間に弾性層に剪断歪みが加えられた時に、結果として形成された積層構造体に対する粘弾性ポリマの吸収効果によって、組み合わせシートによって形成された構造体の望まれない振動、共振、残響を低減させる。本発明は、また、この構造体を製造する方法に関する。
Patent JP-2001527529-A (JP)
IPC: A61P33/00
Filed: 1998-01-29
Abstract: Administration of an antibody reactive to procalcitonin and/or its components is effective for the treatment and/or prevention of systemic inflammatory response syndrome (SIRS) and sepsis.
Patent JP-2001508072-A (JP)
Title: ビス−（４−ヒドロキシアリール）アルカン類の製造方法
IPC: C07C37/20
Filed: 1998-01-07
Abstract: (57)【要約】
反応が進行するにつれてより高い温度で操作される、直列に連結されている少なくとも２つの反応器中での芳香族ヒドロキシ化合物とケトン類との不均一系接触反応によるビス−(４−ヒドロキシアリール)アルカン類の製造方法が開示されている。ケトンの全量は個々の反応器間で反応器の温度が高くなればなるほどケトンのその割合が低くなるように分配される。反応器の充填量はできるだけ高く保たれそして温度および温度勾配はできるだけ低く保たれる。
Patent JP-H11506429-A (JP)
Title: 抗細菌セファロスポリン類
IPC: C07D513/04
Filed: 1996-05-10
Abstract: (57)【要約】
式
 〔式中、Ａｃ、Ｒ 1 およびＲ 2 は種々の意味を有する〕の化合物、その製造法およびその医薬としての、即ち、抗微生物剤としての使用。
Patent JP-H10507082-A (JP)
IPC: C12N15/52
Filed: 1996-05-02
Abstract: The present invention provides a process for the biotransformation of a carbohydrate carbon source to 1,3-propanediol using mixed yeast and bacterial cultures wherein the carbohydrate is first fermented to glycerol by the yeast cell and then converted to 1,3-propanediol by the bacterial cell containing an active diol or glycerol dehydratase enzyme in this process both the yeast and bacterial cultures are supported on the same carbon source, and 1,3-propanediol is isolated from the media.
Patent JP-H11507440-A (JP)
Title: 異なる波長の放射線を使用した混濁媒体中の対象の局部化
IPC: A61B5/145
Filed: 1997-04-01
Abstract: (57)【要約】
混濁媒体（２）の中の対象（１）を検査するシステムは、望ましくは６００ｎｍ乃至１μｍの範囲内の異なる波長の放射成分で混濁媒体を照射する放射線源（３）からなる。放射線成分は、望ましくは逆相で振幅変調される。混濁媒体からの放射線は、異なる波長に対して感度のある光検出器（４）によって受信される。混濁媒体中の異質物は光検出器における振幅変調の重ね合わせに影響を与え、それにより光検出器は混濁媒体中の対象の存在及び／又は位置の情報を含む信号を出力する。
Patent JP-2000507902-A (JP)
Title: ワイパブレードの状態を検出する装置
IPC: B60S1/08
Filed: 1997-03-21
Abstract: (57)【要約】
本発明は、自動車の少なくとも１つのワイパブレードの状態を検出する装置に関する。装置が状態検出のために雨量センサ（５）を有している。
Patent JP-2001511878-A (JP)
Title: 生地の焼上げオーブン
IPC: H05B6/80
Filed: 1998-02-19
Abstract: (57)【要約】
本発明は、電子レンジタイプの生地焼上げオーブン（１、２）であって、生地を膨張位置に固定し、さらに／または、生地上の材料の焼上げを行うことができるように、生地を膨張させるための部分的な真空（１１）の使用と、同時にまたは連続的に使用される、たとえばマイクロ波（９）及び赤外線（６）による一つまたは複数の焼上げ手段とを組み合わせることを特徴とするオーブンに関する。これらの焼上げ手段は、均等に焼上がるように、垂直軸の周りに(１５、１６、１７)、またその軸に沿って縦方向に（４、２１）回転する焼上げる生地の動きと組み合わせることができる。オーブンの内部で生地が受ける処理、すなわち始動させる一つまたは複数の焼上げシステムの選択と焼上げ時間は、焼上げる生地と求められる目的に応じて、プログラミングされるあるいはプログラミング可能であり、生地台炉床（１６）上の生地の横に記されるコードの読取りに制御される。この装置は、オーブンの中に入れ、またオーブンからとり出すための、生地台炉床の自動化操作システムを備えることもできる。
Patent JP-2001527654-A (JP)
Title: 非常脱出用の照明装置
IPC: F21K2/06
Filed: 1998-02-24
Abstract: (57)【要約】
出口ドア又はハッチ（１）を非常脱出路として明確に標識する働きをする、化学的に活性化させた照明装置が提供される。該装置は、共に混合されたとき、光を発する化合物を形成する２種類の化学剤（Ａ、Ｂ）を利用する。次に、この化合物は脱出出口の周りに形成された透明な導管（２０）を通って進む。化学化合物を形成し得るように混合させた化学剤Ａ、Ｂの各々は、別個のチャンバ（３６、３７）内に貯蔵されている。該装置が作動されると、圧搾ガス（５１）がＣＯ 2 キャニスタから解放され、この圧搾ガスは、化学剤（Ａ、Ｂ）を保持するチャンパ（３６、３７）を圧縮して、化学剤をそのそれぞれのチャンバから中央の混合チャンバ（４４）内に押出し、このチャンバ内にて圧搾ガスは、混合され且つ光を発生する化合物を形成する。次に、この化合物は、脱出口を照明し得るように透明な導管を通って進む。
Patent JP-2001514516-A (JP)
Title: 活性化ビタミンｋ依存性血液因子およびその製造方法
IPC: C12N9/64
Filed: 1998-03-10
Abstract: (57)【要約】
本発明は、植物または原核生物から得られたプロテアーゼにより処理することによるビタミンＫ依存性血液因子の活性化方法に関する。本発明はさらに、本発明にしたがって製造された動物プロテアーゼ汚染を示さない血液因子、並びに医薬調製物および医学的適用のためのセットを含んでなる。
Patent JP-H11510038-A (JP)
Title: 分散型ｒａｍを有しかつセルの利用率が高められた、フィールドプログラマブルゲートアレイ
IPC: H03K19/177
Filed: 1997-05-09
Abstract: (57)【要約】
フィールドプログラマブルゲートアレイは、プログラマブル論理セル（１１；１２）のマトリックスと、ローカルおよび高速バスライン（１９、２１、２３、２５）のバスネットワークとを有する。バスネットワークは、そのマトリックスをセルのブロック（１５）に有効に分割し、各ブロックは自身専用のローカルバスラインの組を有する。高速バスラインは、リピータスイッチ装置（２７）によってセルの１ブロックを越えて延び、リピータスイッチ装置（２７）はまた、ローカルバスラインを高速バスラインに接続する。ブロック間の境界（１３）に行および列に位置合わせされたリピータでセルをブロックへと分けることによって、ブロックの隅には空間が生まれ、そこに、ＲＡＭブロック（８３）、他のメモリ構造、特定の論理構造、または他の専用機能素子が入れられて、バスネットワークに接続される。ＲＡＭブロック（図１３）は、バスライン（８６、１７８、１７９）を介してアドルスされるシングルポートまたはデュアルポートのＳＲＡＭ（８５）であり得る。
Patent JP-2000512536-A (JP)
IPC: A47G25/32
Filed: 1998-04-16
Abstract: A folding hanger apparatus particularly useful in luggage has two central portions which are hinged together a pivot between an open position and a closed position, and a hook portion having a hinged connection to one of the central portions. Clothing placed upon the hanger can be hung in an unfolded condition when the hanger is in the open position, and the hanger can be folded to the closed position while clothing is hanging thereon so that the clothing can be hung in a vertically folded position within a confined container such as luggage. The hook pivots to a position pressed against the clothing to prevent the clothing from sliding off the folded hanger. When the hanger is in the unfolded position, the hook portion can be pivoted to an extended position to be used to hang the hanger from a conventional closet rod. A pant loop is provided to permit pants and other garments to be suspended from the bottom of the hanger. The pant loop is movable from side to side to permit the loaded hanger to balance when in the unfolded position, and to permit the hanger to pivot to the folded position. A useful trolley system within a luggage case permits the hanger to be temporarily secured in the folded position within the luggage case. <IMAGE>
Patent MD-20010016-A (MD)
Title: Artificial flower
Inventor: VASILEVSCHII VALERIU
IPC: A41G1/00
Filed: 2001-01-11
Abstract: The invention relates to the light industry, in particular to an artificial flower with illumination.The artificial flower contains a stem of plastic material, wherein it is installed a current source with conductors, cuttings with leaves, roots with covers, petals of silk with an electric bulb inside the bush, a sepal with a thread screwed into a vessel with liquid, and a switch.Novelty of the invention consists in that the vessel with liquid is combined with the goblet.
Patent NZ-214925-A (NZ)
Title: A bottle and closure cap: reservoir in cap
Inventor: ITZEL H
IPC: B65D51/28
Filed: 1986-01-24
Abstract: Closure caps for binary packaging systems comprising an active ingredient concentrate component and a dilutent component, which allow the user to admix the two components without coming in contact with either of them or with the resulting mixture.
Patent NZ-250550-A (NZ)
Title: Phosphonooxymethyl ethers of taxane derivatives and medicaments
Inventor: GOLIK JERZY
IPC: C07D305/14
Filed: 1993-12-22
Abstract: The present invention concerns novel water-soluble phosphonooxymethyl ethers of taxane derivatives, their use as antitumor agents, and pharmaceutical compositions containing the novel compounds.
Patent NZ-264194-A (NZ)
Title: Paint roller with collapsible handle
Inventor: TADECK ZULICK
IPC: B05C1/02
Filed: 1994-08-08
Abstract: The roller consists of a stirrup-shaped holder (4) for the roller, and a handle (1) which is made in two lengthwise sections (2,3) which can clip together when in use and be folded parallel to the lengthwise axis of the holder, e.g. for packaging. The handle and holder are moulded from plastics in one piece with hinges (42,43) for the two handle sections. A projection (44) on the holder engages with two cavities (11) in the handle sections when they are clipped together.
Patent NZ-271071-A (NZ)
Title: Aryl- or benzo-imidazoazepine derivatives {typically 7,10-dihydro-7-methyl-10-(1-methyl-4-piperidinylidene)imida zo[1,2-a]pyrrolo[3,2-d]-azepin-6(5h)-one}; intermediates including 1-esterified-2-[disubstitutedmethyl-1h-imidazole
Inventor: JANSSENS FRANS EDUARD
IPC: C07D471/04
Filed: 1994-07-06
Abstract: PCT No. PCT/EP94/02287 Sec. 371 Date Dec. 13, 1995 Sec. 102(e) Date Dec. 13, 1995 PCT Filed Jul. 6, 1994 PCT Pub. No. WO95/02600 PCT Pub. Date Jan. 26, 1995The present invention is concerned with novel imidazoazepines of formula    <IMAGE>  (I)  the pharmaceutically acceptable addition salts and stereochemically isomeric forms thereof, wherein each of the dotted lines independently represents an optional bond; -A-B- is a radical of formula -X-CH=CH- (a-1); -CH=CH-X- (a-2); or -CH=CH- CH=CH- (a-3); X represents O, S or NR1; R1 represents hydrogen or C1-6alkyl; +E,ovs -----+EE Y is a radical of formula =O (b-1); -OH (b-2); or =N-OH (b-3); and L represents hydrogen, C1-4alkylcarbonyl, C1-4alkyloxycarbonyl, phenylcarbonyl, C1-6alkyl or C1-6alkyl substituted with C1-4alkyloxycarbonyl, hydroxycarbonyl, aryl, aryloxy or a radical of formula    <IMAGE>  (c)  -D-Z- is -S-CH=CH-, -S-CH2-CH2-, -S-CH2-CH2-CH2-, -CH=CH-CH=CH- or -CH2-CH2-CH2-CH2-; and aryl is phenyl or phenyl substituted with halo, hydroxy or C1-4alkyloxy. Compositions comprising said compounds, processes for preparing the same and the use of these compounds for treating allergic diseases.
Patent NZ-277327-A (NZ)
Title: Vessel for mixing pulp and processing liquid: two cylindrical flow dividing surfaces diametrically opposite agitator
Inventor: FORSLUND KJELL
IPC: B01F27/71
Filed: 1994-10-27
Abstract: PCT No. PCT/SE94/01009 Sec. 371 Date May 22, 1996 Sec. 102(e) Date May 22, 1996 PCT Filed Oct. 27, 1994 PCT Pub. No. WO95/17243 PCT Pub. Date Jun. 29, 1995Mixing devices for mixing a processing agent with a pulp suspension are disclosed including a mixing vessel, an agitator mounted on the surface of the mixing vessel to create a flow of the pulp suspension across the mixing vessel, a processing agent supply for supplying processing agent to the flow of pulp suspension, and a flow divider mounted on the inner surface of the mixing vessel opposite the agitator, in which the flow divider includes a substantially vertical front distribution edge and a pair of arcuate front surfaces extending from that edge to the inner surface of the mixing vessel on opposite sides thereof.
Patent NZ-278607-A (NZ)
Title: Use of tnf antagonists for treating disorders involving elevated serum levels of il-6 wherein the serum levels are 500pg/ml or above
Inventor: STENZEL ROSWITHA
IPC: A61P31/04
Filed: 1994-03-19
Abstract: The invention relates to the use of TNF antagonists for producing drugs for the treatment of disorders characterized by elevated serum levels of interleukin-6.
Patent NZ-282199-A (NZ)
Title: Acoustic radiation for bone fracture therapy
Inventor: WINDER ALAN A
IPC: A61B17/225
Filed: 1995-02-17
Abstract: A transducer for non-invasive transcutaneous transmission of pulsed ultrahigh-frequency acoustic radiation, in body tissue and/or fluids adjacent a bone fracture is "on target" when a fraction of the propagated energy within the longitudinal-response lobe of the transducer encounters a crack or other open feature of the fracture, where a gap or space exists between closely spaced fracture walls. The ultrahigh-frequency acoustic radiation sees this "on target" feature as the entrance to a waveguide, whereby pulsed ultrahigh-frequency acoustic radiation is guided within the crack. When this acoustic radiation encounters a gap of at least a quarter wavelength (at the ultrahigh frequency), a standing wave condition establishes itself, with dissipation of the ultrahigh frequency and with demodulation to establish a therapeutically beneficial low-frequency acoustic condition, within the fracture, and acting where most needed, namely, on and between wall regions of adjacent fragments of the broken bone. Collagen, callus and cartilage development is accelerated, closing the gap in a matter of days, so that thereafter zone-flooding of shear waves from transducer radiation can be osteogenically operative upon both bone fragments of the fracture and on the collagen through which they are united at first tentatively and then increasingly more securely as treatment continues, from day to day, as with one or more single treatments of 20 minutes per day.
Patent NZ-299647-A (NZ)
Title: Use of polymeric binder in the formation of refractory articles
Inventor: BOGAN LEONARD EDWARD
IPC: B22F1/10
Filed: 1996-10-25
Abstract: A method for forming parts from inorganic particulate materials is disdosed. The method utilizes a two-component binder composition which is removable at a faster rate than conventional binder compositions, thereby reducing the formation of voids and cracks that occur during binder removal. No toxic materials are required and the method does not rely on solvents. The method may be used with ceramics, metals, and cermets.
Patent NZ-309051-A (NZ)
Title: Use of mannanases as slime control agents
Inventor: VAN PEE KRISTINE LAURA IGNATIU
IPC: D21H21/04
Filed: 1996-05-17
Abstract: The present invention relates to a composition for the prevention and/or removal of biofilm on surfaces comprising at least one mannanase, optionally in combination with at least one enzyme from the group consisting of carbohydrases, proteases, lipases, glycoproteases, and the use of the composition for the prevention and/or the removal of biofilm from surfaces.
Patent NZ-331038-A (NZ)
Title: Washing machine clutch either fixing tub or causing it to rotate with agitator with fixing position at predetermined rotational position of tub
Inventor: HISANO KOJI
IPC: H02K9/06
Filed: 1998-07-20
Abstract: Clutch 39 is moved between the solid and chain dotted positions shown, to respectively either prevent  or provide rotation of tub 21.  Clutch 39 is actuated by lever 44 rotating about screw 43 and engages in the first position only at predetermined rotational positions of tub 21.
Patent NZ-332049-A (NZ)
Title: 2-(2-Hydroxy aryl)-thiazoline-4-carboxylic acids and derivatives as chelators of trivalent metal ions in therapeutic applications
Inventor: BERGERON RAYMOND J JR
IPC: C07D277/12
Filed: 1997-03-31
Abstract: 2-(2-Hydroxy aryl)-thiazoline-4-carboxylic acids and derivatives thereof are valuable bioactive chelators or sequestrants for trivalent metal ions such as Fe, Al and Cr.  They can be administered to human and nonhuman mammals to prevent the deposition of metal ions in body tissues. They are also useful for the elimination of iron from mammals afflicted with conditions such as haemochromatosis, haemosiderosis and cirrhosis.  Chelation therapy using the thiazoline acid derivatives also has applications in dialysis, encephalopathy, osteomalacia and treatment of Alzheimer's disease. One embodiment relates to compounds (I)-(VI) shown.
Patent NZ-332103-A (NZ)
Title: Triphenyl methane compounds or analogues thereof where one or more of the phenyl groups is substituted and the tertiary carbon atom is replaced for sickle cell disease,
Inventor: BRUGNARA CARLO
IPC: C07C259/06
Filed: 1997-03-19
Abstract: The triphenylmethane compound has the formula (A) or a pharmaceutically acceptable salt or hydrate thereof wherein n is 0 to 4; R1 is -H, -OR, -SR, -CN, -C(O)R, -C(S)R, -C(O)OR, -C(S)OR, -C(O)SR, -C(S)SR, -C(O)NR2, -C(S)NR2, -CH[C(O)R]2, -CH[C(S)R]2, -CH[C(O)OR]2, -CH[C(S)OR]2, -CH[C(O)SR]2 or -CH[C(S)SR]2; R2 is F, Cl, Br or I; R3 is R, OR or SR; R4 is H or NR2; R4' is H, F, Cl, Br or I and each R is H, alkyl, alkenyl, alkynyl or alkoxy with the proviso that (i) when n is 0 and R1 is H or OH, R2 is Cl, R4 =  R4' then R3 is other than H and (ii) when n is 0 and R1 is H, R2 is Cl, R4 =  R4' then R3 is other than OH. The triphenylmethane compound has the formula (B) or a pharmaceutically acceptable salt or hydrate thereof wherein n is 0 to 4; R1 is NR2, C(O)R, -C(S)R, -C(O)NR'2 or -C(S)NR'2; R2 is F, Cl, Br or I; R3 is F, Cl, Br or I; R4 is F, Cl, Br or I and each R and R' are independently H, alkyl, alkenyl, alkynyl or alkoxy. The triphenylmethane compound can also has the formula (C) or a pharmaceutically acceptable salt or hydrate thereof wherein n is 0 to 4; Ar1 is phenyl or cyclohexyl; R1 is NR2, -C(O)NR2, -C(S)NR2, -CH[C(O)OR]2, -CH[C(S)OR]2, -CH[C(O)SR]2 or -CH[C(S)SR]2 and each R is H, alkyl, alkenyl, alkynyl or alkoxy; with the proviso that when R1 is NH2 or -C(O)NH2, n is 1, 2 or 3. A pharmaceutical composition thereof useful for: a) inhibiting calcium-activated potassium transport of a cell, b) reducing sickle erythrocyte dehydration or delaying the occurrence of erythrocyte sickling or deformation, c) treating or preventing sickle cell disease or d) for inhibiting mammalian cell proliferation.
Patent NZ-336131-A (NZ)
Title: Method for attaching reclosable zipper strips transversely to thermoplastic film material to make bags
Inventor: VAN ERDEN DONALD L
IPC: B31B19/90
Filed: 1999-06-04
Abstract: The zipper strip includes male and female profiles. The male profile includes a male interlocking member and an integral web comprising a trailing flange, and optionally, a leading flange.  Likewise, the female profile includes a female interlocking member and an integral web comprising a trailing flange, and optionally, a leading flange.  The zipper is attached to thermoplastic film material in a form-fill-seal (FFS) machine.  As the film material is advanced into the machine in bag length increments, the interlocked zipper strip is disposed onto the material transversely, with the trailing flange oriented in a direction opposite to the motion of the film material.  The zipper strip is then sealed to the film material at its extremities in a continuous manner or in the form of spot seals.
Patent NZ-336555-A (NZ)
Title: A recombinant molecule containing the DefH9 promoter combined with a DNA sequence useful for producing parthenocarpic transgenic plants and enhancing fruit setting and development
Inventor: SPENA ANGELO
IPC: C12N15/82
Filed: 1997-12-19
Abstract: A recombinant DNA molecule comprises: a) the promoter of the Deficiens 9 (DefH9) or promoter of a homologous gene to DefH9 which encodes a protein structurally and functionally homologous to the DefH9 gene product from Anthirrhinum majus and having a sequence identity to the coding region of the DefH9 gene of Anthirrhinum majus of at least 40%; the promoter is capable of conferring placenta and /or ovule specific expression and b) operatively lined thereto a DNA sequence which upon expression in plant cells leads to either disabling or killing of the plant cells or the increase of intracellular content and/or activity of at least one auxin. The above DNA molecule is used for the establishment of parthenocarpy or for enhancing fruit setting and development.
Patent NZ-500345-A (NZ)
Title: Fluid flow apparatus
Inventor: PINKERTON ROBERT N
IPC: G01F1/44
Filed: 1998-04-16
Abstract: The specification describes a fluid flow apparatus and, in particular, fluid flowmeters, fluid mixers and fluid dispersing devices.  The apparatus is best illustrated by referring first to FIG. 5 and to the fluid flowmeter.which is, indicated generally at 10.  The fluid flowmeter is adapted to be installed in a pipeline or other fluid flow conduit.  The conduit is depicted as being comprised of pipe sections 12 having bolting flanges 14 at their ends. The flowmeter 10 is comprised of a meter body 20 and a fluid flow displacement device 40 mounted coaxially within the body. The meter body 20 comprises, in essence, a section of pipe or conduit adapted to be bolted or otherwise secured between two sections of pipe, for example, between the flanges 14 of the illustrated pipe sections 12. The meter body is preferably of the so-called wafer design and is simply confined between the flanges 14 and centered or axially aligned with the pipe sections 12 by means of circumferentially spaced bolts 16 (only one shown) extending between and interconnecting the flanges.  The body section 20 has an internal bore or through hole 22 which in use comprises a part of, and constitutes a continuation of the path of fluid flow through, the pipe line 12. As indicated by the arrow, the direction of fluid flow is from left to right as viewed in the drawings. The pipe line 12 and conduit section 20 are usually cylindrical and the bore 22 is usually, though not always, of the same internal cross section and size as the pipe sections 12.  Longitudinally spaced pressure taps 24 and 26 extend radially through the wall of the body 20.